文献速递皮肤肿瘤

用于识别前哨淋巴结活检阴性高危黑色素瘤患者的列线图

A nomogram to identify high-risk melanoma patients with a negative sentinel lymph node biopsy.
PubMed 文献 · J Am Acad Dermatol · 2018-11-02

该回顾性单中心队列纳入2000-2015年接受前哨淋巴结活检的1213例患者,其中967例(79.7%)活检阴性,平均随访59.67个月,复发133例(13.8%)。Breslow厚度、溃疡和微卫星灶可预测1、2、5、10年复发风险,据此构建的列线图有助于识别需更严格监测和考虑辅助治疗的高危患者。

要点

  • 前哨淋巴结活检阴性患者中复发133例(13.8%),其中淋巴结复发45例(33.8%),活检部位复发35例(26.3%)。
  • Breslow厚度、溃疡和微卫星灶可预测1、2、5、10年复发风险。
  • 列线图易于使用,可识别前哨淋巴结活检阴性患者中的高危人群。

核心结论

  • 作者构建了用于前哨淋巴结活检阴性黑色素瘤患者的预测列线图,可识别应接受更严格监测并考虑辅助治疗的高危患者。

研究设计与样本

  • 回顾性队列研究,纳入2000-2015年在一家机构接受前哨淋巴结活检的患者,共1213例。

主要发现

  • 1213例患者中967例(79.7%)前哨淋巴结活检阴性,平均随访59.67个月。
  • 共133例(13.8%)复发,其中45例(33.8%)为淋巴结复发,35例(26.3%)在行前哨淋巴结活检的部位复发。
  • Breslow厚度、溃疡和微卫星灶可预测1年、2年、5年和10年复发风险。

临床怎么用

  • 作者认为该列线图易于使用,可识别前哨淋巴结活检阴性患者中应接受更严格监测并考虑辅助治疗的高危患者。

局限性

  • 单中心分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Melanoma patients with negative nodes after sentinel lymph node biopsy are a heterogeneous group. Current guidelines fail to adequately stratify surveillance and treatment for this group. Also, there is scarce data on adjuvant treatments for these patients. OBJECTIVE: To create a nomogram including clinical and pathologic characteristics capable of evaluating the risk for recurrence of primary melanoma patients with negative sentinel lymph node biopsies (SLNBs). METHODS: We used a retrospective cohort of patients who underwent SLNB during 2000-2015 at a single institution. RESULTS: Our cohort comprised 1213 patients. Among these patients, 967 (79.7%) had a negative SLNB, and mean follow-up was 59.67 months. There were 133 recurrences (13.8%); 45 (33.8%) presented with nodal recurrence, and 35 (26.3%) recurred where a SLNB was performed. Breslow thickness, ulceration, and microsatellitosis were found to be predictive of risk for recurrence at 1, 2, 5, and 10 years. LIMITATION: Single center analysis. CONCLUSION: We created a predictive nomogram for melanoma patients with negative SLNBs. This nomogram is easy to use and identifies high-risk patients who should have more strict surveillance and be considered for adjuvant treatment.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Bertolli E, de Macedo MP, Calsavara VF, et al. A nomogram to identify high-risk melanoma patients with a negative sentinel lymph node biopsy. J Am Acad Dermatol. 2018. PMID: 30395920. doi:10.1016/j.jaad.2018.10.060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。